Nome |
# |
The role of microbiota in autism spectrum disorders, file e27ce42e-a26c-2581-e053-d805fe0acbaa
|
1.462
|
Serum zonulin in patients with inflammatory bowel disease: a pilot study, file e27ce42e-91b3-2581-e053-d805fe0acbaa
|
1.180
|
Dual biological therapy with anti-TNF, vedolizumab or ustekinumab in inflammatory bowel disease: a systematic review with pool analysis, file e27ce42d-ffc9-2581-e053-d805fe0acbaa
|
731
|
Prospective randomized trial: Endoscopic follow up 3 vs 6 months after esophageal variceal eradication by band ligation in cirrhosis, file e27ce427-0ae4-2581-e053-d805fe0acbaa
|
695
|
Risk of drug interactions and prescription appropriateness in elderly patients, file e27ce42e-d9db-2581-e053-d805fe0acbaa
|
608
|
Eosinophilic colitis: clinical review and 2020 update, file e27ce430-0316-2581-e053-d805fe0acbaa
|
589
|
Dupilumab to target interleukin 4 for inflammatory bowel disease? Hypothesis based on a translational message, file e27ce42e-c4db-2581-e053-d805fe0acbaa
|
578
|
Pharmacological considerations and step-by-step proposal for the treatment of Helicobacter pylori infection in the year 2018, file e27ce42e-7e09-2581-e053-d805fe0acbaa
|
540
|
Proctitis: a glance beyond inflammatory bowel diseases, file e27ce430-2f0b-2581-e053-d805fe0acbaa
|
474
|
Fecal calprotectin: beyond intestinal organic diseases, file e27ce42e-c975-2581-e053-d805fe0acbaa
|
461
|
Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis, file e27ce42a-c3b5-2581-e053-d805fe0acbaa
|
425
|
Effectiveness and safety of adalimumab biosimilar ABP 501 in Crohn's disease: an observational study, file e27ce42f-4b41-2581-e053-d805fe0acbaa
|
400
|
Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis, file e27ce42e-8e39-2581-e053-d805fe0acbaa
|
374
|
Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agents, file e27ce42e-a4c2-2581-e053-d805fe0acbaa
|
358
|
Risk factors of suspected spondyloarthritis among inflammatory bowel disease patients, file e27ce42e-6dd7-2581-e053-d805fe0acbaa
|
352
|
Usefulness of the index of NASH – ION for the diagnosis of steatohepatitis in patients with Non-Alcoholic Fatty Liver: an external validation study, file e27ce42c-6c73-2581-e053-d805fe0acbaa
|
343
|
Hepatitis B core-related antigen kinetics in chronic hepatitis B virus genotype D-infected patients treated with nucleos(t)ide analogues or pegylated-interferon-α, file e27ce42b-ae29-2581-e053-d805fe0acbaa
|
321
|
DURABILITY OF THE RESPONSE TO PEGINTERFERON ALFA2b AND RIBAVIRIN IN CHRONIC HEPATITIS C PATIENTS: A COHORT STUDY IN THE ROUTINE CLINICAL SETTING., file e27ce426-fea5-2581-e053-d805fe0acbaa
|
279
|
Pediatric epilepsy and psychiatric comorbidity: could celiac disease diagnosis improve the outcome?, file e27ce42d-474c-2581-e053-d805fe0acbaa
|
262
|
Differential diagnosis of pancreatic cysts: A prospective study on the role of intra-cystic glucose concentration, file e27ce430-7ba7-2581-e053-d805fe0acbaa
|
252
|
Hepatitis B Core-Related Antigen: A Serum Biomarker for Intrahepatic Covalently-Closed-Circular DNA, file e27ce42e-a67c-2581-e053-d805fe0acbaa
|
250
|
Adalimumab versus azathioprine to halt the progression of bowel damage in Crohn’s disease: application of Lémann Index, file e27ce42f-27c8-2581-e053-d805fe0acbaa
|
250
|
Is there a link between periampullary diverticula and biliopancreatic disease? An EUS approach to answer the question, file e27ce42e-79ce-2581-e053-d805fe0acbaa
|
241
|
Management of Pt1 tumours removed by endoscopy during colorectal cancer screening: Outcome and treatment quality indicators, file e27ce42d-404b-2581-e053-d805fe0acbaa
|
240
|
Vedolizumab for treatment of chronic refractory pouchitis: a systematic review with pool analysis, file e27ce42e-e7f3-2581-e053-d805fe0acbaa
|
232
|
Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection, file e27ce42d-2ee7-2581-e053-d805fe0acbaa
|
231
|
Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II, file e27ce42f-18ea-2581-e053-d805fe0acbaa
|
226
|
Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single center retrospective study, file e27ce42e-18f4-2581-e053-d805fe0acbaa
|
218
|
Prevalence of Micronutrient Deficiency in Patients with Morbid Obesity Before Bariatric Surgery: What About Celiac Disease?, file e27ce42d-65c4-2581-e053-d805fe0acbaa
|
214
|
Endoscopic ultrasound to diagnose pneumatosis cystoides intestinalis (with video), file e27ce42e-a30e-2581-e053-d805fe0acbaa
|
200
|
Awareness of mutational artefacts in suboptimal DNA samples: possible risk for therapeutic choices, file e27ce42e-b633-2581-e053-d805fe0acbaa
|
198
|
A rare case of gastric fistulization of a main-duct intraductal papillary mucinous neoplasm, file e27ce42e-79ab-2581-e053-d805fe0acbaa
|
186
|
Favorable short-term outcome of hepatitis C virus–positive liver graft with bridging fibrosis: A plea for very early viral eradication, file e27ce42b-d286-2581-e053-d805fe0acbaa
|
185
|
Helicobacter pylori and proton pump inhibitor therapy: One diagnostic method is enough?, file e27ce42d-594b-2581-e053-d805fe0acbaa
|
182
|
Severe ulcerative colitis: predictors of response and algorithm proposal for rescue therapy, file e27ce42d-2549-2581-e053-d805fe0acbaa
|
177
|
Adalimumab trough levels predict Crohn's disease clinical course, file e27ce42d-5943-2581-e053-d805fe0acbaa
|
177
|
Helicobacter pyloriinfection and asthma: Is there a direct or an inverse association? A meta-analysis, file e27ce42b-5b09-2581-e053-d805fe0acbaa
|
168
|
OC. 12.4 PRIMARY SCLEROSING CHOLANGITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE: ANALYSIS OF INTESTINAL OUTCOME AFTER LIVER TRANSPLANTATION, file e27ce42c-ddfa-2581-e053-d805fe0acbaa
|
165
|
The adherence to the therapy in inflammatory bowel disease: beyond the number of the tablets, file e27ce42d-3314-2581-e053-d805fe0acbaa
|
159
|
Microscopic colitis in patients with mild duodenal damage: A new clinical and pathological entity ("lymphocytic enterocolitis")?, file e27ce42a-d34c-2581-e053-d805fe0acbaa
|
150
|
Progressive increase of matrix metalloprotease-9 and interleukin-8 serum levels during carcinogenic process in human colorectal tract, file e27ce426-ee9a-2581-e053-d805fe0acbaa
|
145
|
AMOXYCILLIN AND METRONIDAZOLE THERAPY FOR HELICOBACTER PYLORI ERADICATION: A 10-YEAR TREND IN TURIN, ITALY, file e27ce42b-7292-2581-e053-d805fe0acbaa
|
145
|
Peripheral neuropathy after viral eradication with direct-acting antivirals in chronic HCV hepatitis: A prospective study, file e27ce432-93a4-2581-e053-d805fe0acbaa
|
145
|
Food supplements, stress and gastrointestinal diseases, file e27ce42d-4de0-2581-e053-d805fe0acbaa
|
136
|
Predictors of risk of fracture in inflammatory bowel diseases: a prospective study using FRAX score, file e27ce42f-e092-2581-e053-d805fe0acbaa
|
131
|
The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational Study, file e27ce430-db6b-2581-e053-d805fe0acbaa
|
127
|
Efficacy of amoxycillin and clarithromycin-based triple therapy for Helicobacter pylori eradication: a 10-year trend in Turin, Italy, file e27ce42e-c7ca-2581-e053-d805fe0acbaa
|
122
|
Basic and clinical aspects of resistin, file e27ce42e-afb7-2581-e053-d805fe0acbaa
|
121
|
Helicobacter pylori and respiratory diseases: 2021 update, file e27ce433-6690-2581-e053-d805fe0acbaa
|
120
|
Response to: Comment on "efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients", file e27ce42b-5401-2581-e053-d805fe0acbaa
|
119
|
Negativization of viremia prior to liver transplant reduces early allograft dysfunction in hepatitis C recipients, file e27ce42d-7a1c-2581-e053-d805fe0acbaa
|
119
|
A Retrospective Experience of Helicobacter pylori Histology in a Large Sample of Subjects in Northern Italy, file e27ce432-79b6-2581-e053-d805fe0acbaa
|
114
|
Gastric emptying and related symptoms in patients treated with buspirone, amitriptyline or clebopride: a "real world" study by 13C-octanoic acid breath test, file e27ce42f-03ad-2581-e053-d805fe0acbaa
|
109
|
Epatocarcinoma: biomarcatori nella prevenzione, diagnosi e cura, file e27ce42a-f451-2581-e053-d805fe0acbaa
|
107
|
Risk of microangiopathy in type 2 diabetes mellitus patients with or without chronic hepatitis C: Results of a retrospective long-term controlled cohort study, file e27ce427-0b92-2581-e053-d805fe0acbaa
|
100
|
Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients, file e27ce42e-885a-2581-e053-d805fe0acbaa
|
100
|
Liver fibrosis: the 2017 state of art, file e27ce42f-18e8-2581-e053-d805fe0acbaa
|
100
|
Helicobacter pylori infection and ischemic heart disease: could experimental data lead to clinical studies?, file e27ce42e-66ef-2581-e053-d805fe0acbaa
|
99
|
Comment on "Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp", file e27ce42c-700e-2581-e053-d805fe0acbaa
|
95
|
Comment on Helicobacter pylori seroprevalence and the occurrence and severity of psoriasis, file e27ce42e-a17a-2581-e053-d805fe0acbaa
|
95
|
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report, file e27ce430-55fd-2581-e053-d805fe0acbaa
|
94
|
Bile acids composition modulate insulin resistance in non-diabetic patients with NAFLD, file e27ce42c-597f-2581-e053-d805fe0acbaa
|
91
|
The first-line treatment of Helicobacter pylori infection in Piedmont in the year 2017, file e27ce42d-675b-2581-e053-d805fe0acbaa
|
89
|
Rifabutin-Based Rescue Therapy for Helicobacter pylori Eradication: A Long-Term Prospective Study in a Large Cohort of Difficult-to-Treat Patients, file e27ce42d-c9dd-2581-e053-d805fe0acbaa
|
88
|
Does Helicobacter pylori infection increase the risk of adult-onset asthma?, file e27ce42d-2eb2-2581-e053-d805fe0acbaa
|
87
|
Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma, file e27ce431-b21b-2581-e053-d805fe0acbaa
|
87
|
Letter: biologics treatment in Crohn's disease and risk of bowel resection-what about the patients who stop anti-TNF therapy?, file e27ce42d-244b-2581-e053-d805fe0acbaa
|
86
|
Incidence of Prostate Cancer in Inflammatory Bowel Disease: A Meta-Analysis, file e27ce430-0314-2581-e053-d805fe0acbaa
|
85
|
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases, file e27ce42f-7113-2581-e053-d805fe0acbaa
|
81
|
Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma, file e27ce430-7f9e-2581-e053-d805fe0acbaa
|
80
|
Oral Manifestations of Inflammatory Bowel Disease and the Role of Non-Invasive Surrogate Markers of Disease Activity, file e27ce42f-d807-2581-e053-d805fe0acbaa
|
71
|
The Effect of Viral Clearance Achieved by Direct-Acting Antiviral Agents on Hepatitis C Virus Positive Patients with Type 2 Diabetes Mellitus: A Word of Caution after the Initial Enthusiasm, file e27ce42f-4e43-2581-e053-d805fe0acbaa
|
70
|
Efficacy of infliximab biosimilars in patients with Crohn's disease, file e27ce42d-6764-2581-e053-d805fe0acbaa
|
69
|
Switching from Biosimilar to Biosimilar Adalimumab, Including Multiple Switching, in Crohn's Disease: A Prospective Study, file e27ce432-4fcf-2581-e053-d805fe0acbaa
|
68
|
Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Diseases, file e27ce42f-ea9c-2581-e053-d805fe0acbaa
|
66
|
Comments on Sulimani et al.: A weekly 35,000 IU vitamin D supplementation improves bone turnover markers in vitamin D deficient Saudi adolescent females, file e27ce42d-5941-2581-e053-d805fe0acbaa
|
63
|
Inflammatory Bowel Disease Nurse—Practical Messages, file e27ce431-fc45-2581-e053-d805fe0acbaa
|
63
|
The hepatitis D virus in Italy. A vanishing infection, not yet a vanished disease, file e27ce433-7ea9-2581-e053-d805fe0acbaa
|
63
|
Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection, file e27ce42f-3175-2581-e053-d805fe0acbaa
|
62
|
Biomarkers of oncogenesis, adipose tissue dysfunction and systemic inflammation for the detection of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease, file e27ce431-fcf2-2581-e053-d805fe0acbaa
|
61
|
Severe Passenger Lymphocyte Syndrome and Acute Rejection in ABO Compatible but non-Identical Liver Transplant Recipient from Hepatitis C Viremic Donor, file e27ce431-294b-2581-e053-d805fe0acbaa
|
60
|
The clinical role of serum epidermal growth factor receptor 3 in hepatitis c virus-infected patients with early hepatocellular carcinoma, file e27ce432-1f74-2581-e053-d805fe0acbaa
|
59
|
Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P, file e27ce430-d1d5-2581-e053-d805fe0acbaa
|
56
|
Efficacy of a preparation based on calcium butyrate, bifidobacterium bifidum, bifidobacterium lactis, and fructooligosaccharides in the prevention of relapse in ulcerative colitis: A prospective observational study, file e27ce433-719d-2581-e053-d805fe0acbaa
|
54
|
Management of Dyspepsia and Gastroparesis in Patients with Diabetes. A Clinical Point of View in the Year 2021, file e27ce431-a53c-2581-e053-d805fe0acbaa
|
53
|
Immunological and virological markers during pegylated interferon therapy in HDV chronic hepatitis: any predictor of response?, file e27ce430-46ab-2581-e053-d805fe0acbaa
|
50
|
Plasma Selenoprotein P levels are related to adipose tissue insulin resistance, composition of free fatty acids and liver fibrosis in non-diabetic patients with Non Alcoholic Fatty Liver Disease, file e27ce42c-40be-2581-e053-d805fe0acbaa
|
49
|
Impact of Macroscopic On-Site Evaluation (MOSE) on Accuracy of Endoscopic Ultrasound-Guided Fine-Needle Biopsy (EUS-FNB) of Pancreatic and Extrapancreatic Solid Lesions: A Prospective Study, file e27ce434-c0c1-2581-e053-d805fe0acbaa
|
49
|
Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease, file e27ce432-4017-2581-e053-d805fe0acbaa
|
47
|
Usefulness of a Hepatitis B Surface Antigen-Based Model for the Prediction of Functional Cure in Patients with Chronic Hepatitis B Virus Infection Treated with Nucleos(t)ide Analogues: A Real-World Study, file e27ce432-61f2-2581-e053-d805fe0acbaa
|
47
|
Serum cytokeratin-19 fragments (CYFRA 21-1) for the prediction of overall survival in patients with hepatocellular carcinoma, file e27ce430-72f2-2581-e053-d805fe0acbaa
|
45
|
Non-organ-specific autoimmunity in patients suffering from gastric ulcer with and without Helicobacter pylori infection, file e27ce42c-01c9-2581-e053-d805fe0acbaa
|
44
|
The combination of Index of NASH score and liver stiffness improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with NonAlcoholic Fatty Liver Disease., file e27ce42a-673d-2581-e053-d805fe0acbaa
|
43
|
Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease, file e27ce434-49d4-2581-e053-d805fe0acbaa
|
39
|
Insulin secretion and decreased glucose clearance are associated with enhanced fibrogenesis and a high risk of disease progression in non-diabetic patients with Non Alcoholic Fatty Liver Disease, file e27ce42b-e2aa-2581-e053-d805fe0acbaa
|
38
|
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development, file 5c38c060-c792-4a26-9202-4b8155c39c61
|
36
|
Use of reflux finding score and reflux symptom index for the management of laryngopharyngeal lesions: a pilot study, file e27ce435-223d-2581-e053-d805fe0acbaa
|
30
|
Angiopoietin like protein 4 (ANGPTL4): a marker of alteration in lipid metabolism, insulin resistance and ectopic fat accumulation, file e27ce42a-3a13-2581-e053-d805fe0acbaa
|
29
|
Hepatic macrophage activation is associated with adipose tissue insulin resistance in non-diabetic patients with Non-Alcoholic Fatty Liver Disease, file e27ce42a-4a77-2581-e053-d805fe0acbaa
|
29
|
Diagnostic accuracy of soluble sCD163 for the detection of severe fibrosis in patients with Non-Alcoholic Fatty Liver Disease, file e27ce42e-b88c-2581-e053-d805fe0acbaa
|
29
|
Totale |
19.492 |